The Female Health Company Schedules Third Quarter Conference Call for Tuesday, August 14, 2007
August 07 2007 - 4:21PM
PR Newswire (US)
CHICAGO, Aug. 7 /PRNewswire-FirstCall/ -- The Female Health Company
-- (AMEX:FHC) today announced that it will host an investor
conference call to discuss its operating results for the third
quarter and first nine months of FY2007. The Company plans to
report its third quarter operating results on the morning of
Tuesday, August 14, 2007, and an investor conference call has been
scheduled for 11:00 a.m. Eastern Time (EDT) on the same day.
Shareholders and other interested parties may participate in the
conference call by dialing 888-694-4676 (international participants
dial 973-582-2737) and referencing the conference ID 9051668, a few
minutes before 11:00 a.m. EDT on August 14, 2007. A replay of the
call will be available through August 28, 2007 by dialing
877-519-4471 (international callers dial 973-341-3080) and entering
the conference ID 9051668. About The Female Health Company, Inc. -
The Female Health Company, based in Chicago, Illinois, manufactures
and markets the FC Female Condom(R), which is primarily distributed
by public health organizations and donor groups in over 90
developing countries around the world. World-wide, the Female
Condom is available in various programs in 108 countries. The
Company owns certain worldwide rights to the FC Female Condom(R),
including patents that have been issued in the United States,
United Kingdom, Japan, France, Italy, Germany, Spain, the European
Patent Convention, the People's Republic of China, Canada, South
Korea and Australia. FC Female Condom(R) is the only available
FDA-approved product controlled by a woman that offers dual
protection against sexually transmitted diseases, including
HIV/AIDS, and unintended pregnancy. "Safe Harbor" statement under
the Private Securities Litigation Reform Action of 1995: The
statements in this release which are not historical fact are
forward-looking statements based upon the Company's current plans
and strategies, and reflect the Company's current assessment of the
risks and uncertainties related to its business, including such
things as product demand and market acceptance; the economic and
business environment and the impact of government pressures;
currency risks; capacity; efficiency and supply constraints; and
other risks detailed in the Company's press releases, shareholder
communications and Securities and Exchange Commission filings.
Actual events affecting the Company and the impact of such events
on the Company's operations may vary from those currently
anticipated. For more information about the Female Health Company
visit the Company's web site at http://www.femalehealth.com/ and
http://www.femalecondom.org/. If you would like to be added to an
e-mail alert list, please send an e-mail to Contacts: William R.
Gargiulo, Jr. 231.526.1244 Donna Felch 312.595.9123 DATASOURCE: The
Female Health Company CONTACT: William R. Gargiulo, Jr.,
+1-231-526-1244, or Donna Felch, +1-312-595-9123, both of The
Female Health Company Web site: http://www.femalehealth.com/
http://www.femalecondom.org/
Copyright
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jul 2023 to Jul 2024